GlaxoSmithKline PLC ADR (GSK) — Cash Flow-to-Debt Ratio
GlaxoSmithKline PLC ADR (GSK) has a Cash Flow-to-Debt Ratio of 0.06x as of June 2026, meaning its operating cash flow of $2.54 Billion could theoretically repay 0% of its total liabilities ($44.29 Billion) in one year. See financial flexibility index of GlaxoSmithKline PLC ADR to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GlaxoSmithKline PLC ADR Cash Flow-to-Debt Ratio (1990–2025)
Historical debt coverage capacity for GlaxoSmithKline PLC ADR across 36 annual periods. For the full cash flow conversion analysis, see GSK cash flow conversion.
Annual Cash Flow-to-Debt Ratio for GlaxoSmithKline PLC ADR (1990–2025)
Year-by-year debt coverage analysis for GlaxoSmithKline PLC ADR. Check GlaxoSmithKline PLC ADR cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | $7.14 Billion | $45.02 Billion | ▲ +12.3% |
| 2024 | 0.14x | $6.55 Billion | $46.38 Billion | ▲ +5.5% |
| 2023 | 0.13x | $7.89 Billion | $58.91 Billion | ▼ -9.4% |
| 2022 | 0.15x | $7.40 Billion | $50.05 Billion | ▲ +45.5% |
| 2021 | 0.10x | $7.95 Billion | $78.23 Billion | ▼ -1.9% |
| 2020 | 0.10x | $8.44 Billion | $81.50 Billion | ▲ +4.9% |
| 2019 | 0.10x | $8.02 Billion | $81.25 Billion | ▼ -36.2% |
| 2018 | 0.15x | $8.42 Billion | $54.39 Billion | ▲ +18.4% |
| 2017 | 0.13x | $6.92 Billion | $52.89 Billion | ▲ +8.9% |
| 2016 | 0.12x | $6.50 Billion | $54.12 Billion | ▲ +108.3% |
| 2015 | 0.06x | $2.57 Billion | $44.57 Billion | ▼ -60.2% |
| 2014 | 0.14x | $5.18 Billion | $35.72 Billion | ▼ -31.2% |
| 2013 | 0.21x | $7.22 Billion | $34.27 Billion | ▲ +67.3% |
| 2012 | 0.13x | $4.38 Billion | $34.73 Billion | ▼ -35.0% |
| 2011 | 0.19x | $6.25 Billion | $32.25 Billion | ▼ -7.9% |
| 2010 | 0.21x | $6.80 Billion | $32.31 Billion | ▼ -13.8% |
| 2009 | 0.24x | $7.84 Billion | $32.12 Billion | ▲ +3.8% |
| 2008 | 0.24x | $7.31 Billion | $31.07 Billion | ▼ -19.5% |
| 2007 | 0.29x | $6.17 Billion | $21.09 Billion | ▲ +14.0% |
| 2006 | 0.26x | $4.08 Billion | $15.90 Billion | ▼ -18.8% |
| 2005 | 0.32x | $6.20 Billion | $19.63 Billion | ▲ +8.7% |
| 2004 | 0.29x | $4.94 Billion | $17.01 Billion | ▼ -7.2% |
| 2003 | 0.31x | $4.85 Billion | $15.49 Billion | ▲ +52.9% |
| 2002 | 0.20x | $3.06 Billion | $14.94 Billion | ▼ -39.7% |
| 2001 | 0.34x | $4.61 Billion | $13.57 Billion | ▲ +131.7% |
| 2000 | 0.15x | $1.85 Billion | $12.63 Billion | ▲ +107.9% |
| 1999 | 0.07x | $510.00 Million | $7.23 Billion | ▲ +13.1% |
| 1998 | 0.06x | $410.00 Million | $6.58 Billion | ▼ -33.6% |
| 1997 | 0.09x | $615.00 Million | $6.55 Billion | ▼ -22.0% |
| 1996 | 0.12x | $849.00 Million | $7.05 Billion | ▼ -19.9% |
| 1995 | 0.15x | $1.25 Billion | $8.32 Billion | ▼ -53.7% |
| 1994 | 0.33x | $2.45 Billion | $7.53 Billion | ▼ -15.4% |
| 1993 | 0.38x | $1.05 Billion | $2.74 Billion | ▲ +16.2% |
| 1992 | 0.33x | $927.00 Million | $2.80 Billion | ▲ +2.9% |
| 1991 | 0.32x | $657.00 Million | $2.04 Billion | ▲ +28.7% |
| 1990 | 0.25x | $615.00 Million | $2.46 Billion | — |